Related Experiment Video

Updated: Jul 3, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals

Yi-Ping Rong1, Ademuyiwa S Aromolaran, Geert Bultynck

  • 1Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Molecular Cell
|July 29, 2008
PubMed

Insights

The antiapoptotic protein Bcl-2 interacts with IP3Rs to inhibit calcium release from the ER. Disrupting this interaction with a peptide reverses Bcl-2

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The antiapoptotic protein Bcl-2 plays a role in regulating cell death pathways.
  • Calcium (Ca2+) signaling is crucial for various cellular processes, including apoptosis.
  • Bcl-2 is known to inhibit Ca2+ release from the endoplasmic reticulum (ER).

Purpose of the Study:

  • To investigate the direct interaction between Bcl-2 and the inositol 1,4,5-trisphosphate receptor (IP3R) Ca2+ channel.
  • To elucidate the mechanism by which Bcl-2 regulates IP3R-mediated Ca2+ release.
  • To explore the therapeutic potential of targeting the Bcl-2-IP3R interaction.

Main Methods:

  • Förster resonance energy transfer (FRET) to document Bcl-2-IP3R interaction in cells.
  • Identification of the Bcl-2 interacting region within the IP3R.
  • In vitro and cellular assays using a peptide to disrupt the Bcl-2-IP3R interaction.

Main Results:

  • Direct interaction between Bcl-2 and IP3Rs was confirmed within cells using FRET.
  • A specific IP3R sequence was identified as the binding site for Bcl-2.
  • A peptide targeting this interaction site reversed Bcl-2's inhibition of Ca2+ release and apoptosis.

Conclusions:

  • The interaction between Bcl-2 and IP3Rs is a key mechanism for Bcl-2 to regulate proapoptotic Ca2+ signals.
  • Targeting the Bcl-2-IP3R interaction can reverse Bcl-2's inhibitory effects on Ca2+ signaling and cell death.
  • The Bcl-2-IP3R interaction represents a potential therapeutic target for diseases involving dysregulated cell death.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...